Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000874015-21-000047)

Filing Details

Accession Number:
0000874015-21-000047
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-25 20:24:13
Reporting Period:
2021-01-21
Accepted Time:
2021-01-25 20:24:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010		 Exec Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-21 13,958 $60.53 555,433 No 4 S Indirect By trust
Common Stock Disposition 2021-01-21 21,042 $61.65 534,391 No 4 S Indirect By trust
Common Stock Disposition 2021-01-22 40,000 $61.68 494,391 No 4 S Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By trust
No 4 S Indirect By trust
No 4 S Indirect By trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,354 Direct
Common Stock 3,111 Indirect By wife
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 2, 2020.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.20 to $61.00, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.25 to $62.15, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4.
  4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $62.00, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) of this Form 4.